file:: [s12998-021-00381-6_1741250494575_0.pdf](../assets/s12998-021-00381-6_1741250494575_0.pdf)
file-path:: ../assets/s12998-021-00381-6_1741250494575_0.pdf

- A prevalence of sleep deprivation(42.2%) has been reported in patients with chronic lower back and neck pain with 19.8%
  ls-type:: annotation
  hl-page:: 2
  hl-color:: yellow
  id:: 67d1a2ef-cc96-4dd1-897c-71d9ab557d83
- The prevalence of insomnia is twice larger in patients with osteoarthritis (OA) (25%) than without(11%)
  ls-type:: annotation
  hl-page:: 2
  hl-color:: yellow
  id:: 67d1a304-f9f4-41b5-ae94-da80e666f6c9
- when they cooccur, their combined impact in lost productivity and personal suffering is magnified
  ls-type:: annotation
  hl-page:: 2
  hl-color:: yellow
  id:: 67d1a34a-a1f0-45ec-9e67-3d5a94e7a232
- Sleep and pain share a complex reciprocal relationship, such that pain disturbs sleep continuity and quality and, conversely, poor sleep can exacerbate pain intensity
  ls-type:: annotation
  hl-page:: 2
  hl-color:: yellow
  id:: 67d1a392-d24d-41e6-84cb-ff315f5d0433
- Tang et al. (2015) reported that non-pharmacological sleep treatments (CBT-I, behavioral therapy, energy, and sleep enhancement) in chronic pain patients were associated with a large improvement in sleep quality and a small reduction in pain at post-treatment for both cancer and non-cancer pain patients
  ls-type:: annotation
  hl-page:: 2
  hl-color:: yellow
  id:: 67d1a7da-b083-4b21-b00d-8621938b96e9
- sleep interventions (e.g., CBT and pharmacological interventions) improved sleep and pain for people with low back pain, and only sleep for people with OA
  ls-type:: annotation
  hl-page:: 2
  hl-color:: yellow
  id:: 67d1a7ee-1cb6-45a6-9f04-d81bec02d9bc
- Excluded: any prescription and over-the-counter pharmacological therapies, herbal and dietary sleep supplements including, but not limited to, oral capsules/pills, patches, sprays, drops, and other liquids
  ls-type:: annotation
  hl-page:: 3
  hl-color:: yellow
  id:: 67d1a82c-98d7-491a-a156-7111873af1df
- A meta-analysis was not conducted due to the clinical, statistical, and methodological heterogeneity of the studies
  ls-type:: annotation
  hl-page:: 4
  hl-color:: yellow
  id:: 67d1aa86-dbc4-4970-9a23-c66b598d039a
- minimal clinically important differences (MCID
  ls-type:: annotation
  hl-page:: 4
  hl-color:: yellow
  id:: 67d1aa8c-d1b9-4711-aa78-aa85891e05da
- 30% change from baseline for 11 outcome
  ls-type:: annotation
  hl-page:: 4
  hl-color:: yellow
  id:: 67d1aa9d-153b-42be-8970-0d48a1ed1d24
  hl-stamp:: 1741794368524
- a 5% greater sleep efficiency (SE
  ls-type:: annotation
  hl-page:: 16
  hl-color:: yellow
  id:: 67d1aab5-8c04-4c6f-adac-c6b51269a648
  hl-stamp:: 1741794374504
- a 3 point reduction for the Pittsburgh Sleep Quality Index(PSQI)
  ls-type:: annotation
  hl-page:: 16
  hl-color:: yellow
  id:: 67d1aabe-ea8d-4764-956c-1aed42617466
  hl-stamp:: 1741794382022
- 2 point reduction for the 8-item Epworth Sleepiness Scale (ESS
  ls-type:: annotation
  hl-page:: 16
  hl-color:: yellow
  id:: 67d1aac7-68af-44ab-b8ee-516f71248d60
  hl-stamp:: 1741794387074
- 40 min increase for Total Sleep Time (TST)
  ls-type:: annotation
  hl-page:: 16
  hl-color:: yellow
  id:: 67d1aad0-c18c-4d52-951a-5fbed94a51fb
  hl-stamp:: 1741794390703
- 30 min reduction for Sleep Onset Latency (SOL)
  ls-type:: annotation
  hl-page:: 16
  hl-color:: yellow
  id:: 67d1aad7-f819-458e-ba11-4ce3aaba4055
  hl-stamp:: 1741794396905
- 30 min reduction for Wake After Sleep Onset (WASO)
  ls-type:: annotation
  hl-page:: 16
  hl-color:: yellow
  id:: 67d1aae0-1e06-4418-96e3-56fad6f37053
  hl-stamp:: 1741794400239
- 4 point reduction for the Tampa Scale for Kinesiophobia (TS
  ls-type:: annotation
  hl-page:: 16
  hl-color:: yellow
  id:: 67d1ab0e-21a6-4f2c-8607-eec98bf8d66a
  hl-stamp:: 1741794401821
- greater than 1 point for Conditioned Pain Modulation
  ls-type:: annotation
  hl-page:: 16
  hl-color:: yellow
  id:: 67d1ab17-65c6-4ddf-a30d-c0a7e07a00be
  hl-stamp:: 1741794403154
- standardized mean difference (SMD)/effect size (e.g., Cohen’s d) ≥0.2
  ls-type:: annotation
  hl-page:: 16
  hl-color:: yellow
  id:: 67d1ab34-53e3-49d9-81a0-62dcdbf6822b
  hl-stamp:: 1741794405038
- measured by wrist actigraphy
  ls-type:: annotation
  hl-page:: 17
  hl-color:: yellow
  id:: 67d1abf9-2f4e-428d-a233-e962dc257bd1
  hl-stamp:: 1741794299522
- Across all intervention arms, short-term (2-month) clinically significant improvements in sleep were not associated with long-term (9- and 18-month) clinically significant improvements in any of the sleep outcomes 
  ls-type:: annotation
  hl-page:: 17
  hl-color:: yellow
  id:: 67d1acd1-9fed-49df-9f1e-a9ee9e389a76
- wake after sleep onset (WASO) measured by diary at posttreatment (2 months) (Cohen’s d − 0.28, 95% CI -0.93, −0.09) and 3 months (Cohen’s d − 0.38, 95% CI -1.16, −0.21), and by polysonography (PSG) at post-treatment(Cohen’s d − 0.31, 95% CI -1.09, − 0.21
  ls-type:: annotation
  hl-page:: 17
  hl-color:: green
  id:: 67d1ad15-ad26-4c9a-bf6e-0d114530d386
- total sleep time (TST) at post-treatment measured by diary(Cohen’s d − 0.49, 95% CI -1.03, − 0.18) and actigraphy(Cohen’s d − 0.44, 95% CI -1.08, − 0.19
  ls-type:: annotation
  hl-page:: 17
  hl-color:: green
  id:: 67d1ad32-d3f4-4078-8d7e-b5a5a66d1e4d
- SE measured by diary at 3 months (Cohen’s d 0.39, 95% CI 0.24, 1.18)
  ls-type:: annotation
  hl-page:: 17
  hl-color:: green
  id:: 67d1ad4f-6b0d-4255-a2b6-85f1b7a9d808
- ISI measured at post-treatment (Cohen’s d − 0.44
  ls-type:: annotation
  hl-page:: 17
  hl-color:: green
  id:: 67d1ad67-a24f-4f67-9f54-eafd6d5f952f
- The intervention was no better than placebo for improving sleep onset latency (SOL) or pain outcomes (VAS, Western Ontario and McMaster Universities Arthritis Index [WOMAC] pain subscale, Conditioned Pain Modulation, Temporal Summation)
  ls-type:: annotation
  hl-page:: 18
  hl-color:: green
  id:: 67d1adaa-614f-40b6-a2ae-3c0faf521575
- In another secondary analysis, CBT-I was no better than placebo in reducing pain-catastrophizing
  ls-type:: annotation
  hl-page:: 18
  hl-color:: green
  id:: 67d1ae60-0ff7-4f2c-970f-0b67e6a960d2
- changes in sleep are prospectively associated with pain-related outcomes
  ls-type:: annotation
  hl-page:: 19
  hl-color:: yellow
  id:: 67d1aeb1-7bef-4e74-800b-29c900c58293
- strong bi-directional relationship between sleep and pain [2,57]
  ls-type:: annotation
  hl-page:: 20
  hl-color:: yellow
  id:: 67d1af0c-d95a-4794-a229-67b6a09a78dd
- Only two RCTs were identified as relevant in our review
  ls-type:: annotation
  hl-page:: 20
  hl-color:: yellow
  id:: 67d1b371-fa32-47e1-98df-9984726a79f7
- Our review demonstrated that CBT-I or CBT-PI provide some benefits to improving sleep outcomes, but not pain or other health outcomes
  ls-type:: annotation
  hl-page:: 20
  hl-color:: green
  id:: 67d1b3b9-44bc-4e32-9633-1e08c142525b